A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B

Author(s):

Man Fung Yuen, Chi Yi Chen, Chun Jen Liu, Wen Juei Jeng, Magdy Elkhashab, Carla S. Coffin, Won Kim, Susan Greenbloom, Alnoor Ramji, Young S. Lim, Yoon J. Kim, Scott K. Fung, Dong J. Kim, Jeong Won Jang, Kwan Sik Lee, Radhakrishnan P. Iyer, Chelsea Macfarlane, Kathy Jackson, Stephen A. Locarnini, Henry L.Y. Chan, Nezam H. Afdhal

Details:

Liver International, Volume 43, Issue 1, 2023-01-01

Article Link: Click here

Affiliations:

• Seoul National University College of Medicine
• The Catholic University of Korea Seoul St. Mary's Hospital
• The University of Hong Kong, State Key Laboratory of Liver Research
• Gangnam Severance Hospital
• National Taiwan University Hospital
• Chiayi Christian Hospital
• Beth Israel Deaconess Medical Center
• Prince of Wales Hospital Hong Kong
• Toronto General Hospital
• Chang Gung University
• University of Toronto
• University of Ulsan College of Medicine
• Hallym University, College of Medicine
• Royal Melbourne Hospital
• Cumming School of Medicine
• Toronto Digestive Disease Associates
• Spring Bank Pharmaceuticals
• Gastrointestinal Research Institute